Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Diabetes Mellitus, Type 1
About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 1
Eligibility Criteria
Inclusion Criteria:
- age 5-18 years
- diagnosis of type 1 diabetes with a duration of >12 months
- suboptimal glycemic control at time of enrollment, defined as a hemoglobin A1c (HbA1c) level > 8% (64 mmol/mol) or a 14-day glucose management index (GMI) of >8% from continuous glucose monitoring (CGM) data or 14-day average blood glucose of >200 mg/dl in the preceding month
- intention to receive diabetes care at the UCD Pediatric Diabetes Clinic during the following year
- access to the internet via a device with video and audio capability
- ability to connect the patient's home blood glucose meter or CGM device - as well as insulin pump, if applicable - to an internet-capable device via Bluetooth or physical cable.
Exclusion Criteria:
-Patients whose home addresses are not in California (due to current physician licensing restrictions for telehealth services)
Sites / Locations
- University of California-DavisRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Experimental
Supplemental video visits
Standard of Care
Supplemental remote monitoring
Participants in this intervention arm will receive home-based video visits with a pediatric endocrinologist every month for the duration of 6 months in addition to usual care.
The control group will receive usual care, consisting of quarterly visits with the UCD Pediatric Diabetes Clinic.
Participants in this intervention arm will receive remote glucose monitoring with monthly asynchronous outreach from a pediatric endocrinologist for a duration of six months in addition to usual care.